As a slew of new catheter-based devices hit the market, it will be crucial to keep tabs on eligibility, safety, and access, ...

For women—but not men—who are part of the LGBTQ+ community, the overall CV health impact posed by being a sexual minority ...

Following the US approval of the Agent paclitaxel-coated balloon for the treatment of in-stent restenosis (ISR), the first coronary procedures with the device were performed Tuesday morning at two ...

The algorithm can identify noncoronary signals, offering insights into ventricular function and cardiac index, investigators say.

Despite getting even more new data this April supporting the practice of using ticagrelor monotherapy as soon as 1 month after PCI for ACS, many cardiologists seem wary about dropping aspirin so ...

Physicians forced to make rapid-fire choices, with limited evidence, in acute myocardial infarction complicated by ...

LONG BEACH, CA—The long-held practice of requiring patients to fast prior to cardiac catheterization is again being ...

Older patients who have been discharged from the hospital after myocardial infarction are at a significantly lower risk of all-cause mortality if treated with high-intensity lipid-lowering therapy, ...

Lower risks of death and MACE in statin users are intriguing, but need to be confirmed in randomized trials, experts say.

The Society of Thoracic Surgeons (STS) has published three new online calculators that spell out personalized risks for ...

All but one of our top stories this month stemmed from ACC 2024, but not all were from the main tent sessions.

The approval marks the return of the dissolving-scaffold concept, which so far has failed to find success in the coronaries.